In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.
[audio:https://www.audiomedica.com/podcasting/aha2005/Milton_Packer.mp3]
Warfarin Trumps Platelet Agents in Atrial Fibrilation 17 Nov, 2005 Telomere Length Predicts Coronary Heart Disease Risk and Statin Response 19 Jan, 2007 Drug-eluting Stents: No Benefit in Vein Grafts 17 Nov, 2005 Looking for Atherosclerosis in the Legs Could Save Lives 5 Sep, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
